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 highlights 
 Increased GLP-1 levels were found in plasma and colon tissue during 
proestrus. 
 Reduced stomach contents were recorded on the morning of estrus. 
 High GLP-1 at proestrus may indicate increased satiety leading into estrus. 
 Plasma and colon PYY unchanged during estrous cycle; possible differential 
PYY/GLP-1 secretion. 
 Increasing age affects GLP-1 regulatory control in reproductively competent 
females. 
 
 
  
 Abstract: 
There is a well-documented association between cyclic changes to food intake and 
the changing ovarian hormone levels of the reproductive cycle in female mammals. 
Limited research on appetite-controlling gastrointestinal peptides has taken place in 
females, simply because regular reproductive changes in steroid hormones present 
additional experimental factors to account for. This study focussed directly on the 
roles that gastrointestinal-secreted peptides may have in these reported, naturally 
occurring, changes to food intake during the rodent estrous cycle and aimed to 
determine whether peripheral changes occurred in the anorexigenic (appetite-
reducing) hormones peptide-YY (PYY) and glucagon-like peptide-1 (GLP-1) in 
female Wistar rats (32-44 weeks of age). Total forms of each peptide were measured 
in matched fed and fasted plasma and descending colon tissue samples for each 
animal during the dark (feeding) phase. PYY concentrations did not significantly 
change between defined cycle stages, in either plasma or tissue samples. GLP-1 
concentrations in fed plasma and descending colon tissue were significantly 
increased during proestrus, just prior to a significant reduction in fasted stomach 
contents at estrus, suggesting increased satiety and reduced food intake at this 
stage of the cycle. Increased proestrus GLP-1 concentrations could contribute to the 
reported reduction in food intake during estrus and may also have biological 
importance in providing the optimal nutritional and metabolic environment for 
gametes at the potential point of conception. Additional analysis of the findings 
demonstrated significant interactions of ovarian cycle stage and fed/fasted status 
with age on GLP-1, but not PYY plasma concentrations. Slightly older females had 
reduced fed plasma GLP-1 suggesting that a relaxation of regulatory control of this 
incretin hormone may also take place with increasing age in reproductively 
competent females.  
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1 Introduction: 
Reduced food intake in reproductively cycling females has been associated with high 
levels of estradiol in the circulation; rats consume less during estrus, following the 
earlier peak in ovarian estradiol secretion during proestrus [1-3]. Eckel et al. (2000) 
found a significant reduction in food intake at estrus to be accompanied by a 
reduction in water consumption and also reported a significant decrease in body 
mass in ad libitum fed rats. Another study in ovariectomised (OVX) female rats 
further demonstrated that cyclic administration of near physiological estradiol levels 
allowed maintenance of feeding patterns and body mass, both of which were lost in 
non-treated OVX control rats [4]. Despite previously observed cyclic changes to food 
intake and body mass during the reproductive cycle, the optimal nutritional and 
metabolic environment to ensure healthy gametes at the time of ovulation and 
potential conception, prior to early development events, is not well characterised. 
Likewise, the possible roles of appetite-regulating gut hormones at this time have not 
been explored in detail.  
 
Appetite-influencing hormone concentrations in the peripheral circulation, including 
ghrelin, PYY and GLP-1, are generally suppressed in conditions of obesity and in 
type II diabetes [5-9]. Gastrointestinal bypass surgery results in reduced food intake 
and body mass gain, and rapid improvements in glucose homeostasis in people with 
type II diabetes. It is also associated with marked changes to gut hormone secretion, 
with postprandial levels of satiety-inducing gut hormones being significantly 
increased [10-13]. With the globally increased prevalence of obesity in younger 
human populations, new drugs and endogenous hormone combinations are being 
tested as alternatives to risky gastric surgery treatments that are effective in altering 
metabolic/gut hormone profiles towards weight loss. In this context, it will be 
important to establish what effects altering endogenous appetite hormone 
concentrations may have on females of reproductive age. Before such work is 
performed, however, it is necessary to determine how appetite hormone levels 
change during the ovarian cycle, which is the aim of the present study. 
   
PYY and GLP-1 are anorexigenic (appetite-inhibiting) gut peptides that are co-
secreted predominantly from the population of L cells in the distal colon in response 
to intake of specific nutrients in food [reviewed by 14, 15], although recent studies 
using perfused male rat guts ex vivo have demonstrated the presence and variable 
secretion of both peptides from proximal and distal areas of small intestine [16]. PYY 
and GLP-1 are released in a biphasic manner and plasma levels increase from 
approximately 15 minutes after the start of food consumption, proportional to meal 
size, to signal satiety [14, 17]. Both peptides additionally have physical effects on the 
gastrointestinal tract, such as delaying gastric emptying via an ileal brake 
mechanism, and decreasing gastric acid and intestinal secretions [18, 19]. 
Additionally, GLP-1 acts as an incretin, signalling between the gut and pancreatic 
beta cells to increase glucose-dependent insulin secretion [15]. The incretin 
properties of GLP-1 have been utilised to treat type-II diabetes and to achieve 
modest body mass reductions [20]. Little is known about the potential influence of 
the reproductive cycle hormones’ interaction with PYY and GLP-1, but it may be 
anticipated that during estrus, when food intake is lowest, PYY and GLP-1 may 
contribute to the anorexigenic tone.  
 
The main objectives of this study were to establish if any changes in circulating and 
tissue concentrations of the anorexigenic hormones PYY and GLP-1 occurred in 
relation to previously documented natural food intake changes during the rodent 
estrous cycle. It is the first study to consider co-secreted PYY and GLP-1 
concentrations in the same matched fed and fasted plasma and in corresponding 
(fasted) colon tissue samples in female rats at each stage of the estrous cycle. This 
work also took into account the nocturnal feeding patterns of rodents, with 
quantification of hormone concentrations during the dark phase at each estrous 
cycle stage. Secondary aims included checking for any age effects, as data analysis 
of total ghrelin fed and fasted concentrations from the same samples found 
decreased amounts in slightly older females [21].  
 
2. Materials and methods 
2.1 Animals 
This work was licensed under the Home Office Animals (Scientific Procedures) Act 
1986 and had approval from The Open University Ethics Committee; rats were 
specifically chosen for this study to obtain enough blood for fed and fasted 
comparison. Nulliparous female Wistar rats (Harlan, UK, n=43) were housed in 
groups of four and maintained under a 12 hour reverse light cycle (lights off between 
11.00 and 23.00) with free access to standard breeding diet and water. All 
procedures were carried out during the dark phase so that samples were obtained 
when most physiologically relevant for natural feeding behaviour. Females were kept 
near a cage of male rats to keep the females cycling normally. Daily estrous 
monitoring was undertaken at 24-hourly intervals between 11.00 (lights off) and 
13.00 to determine cycle stages by vaginal lavage, as described by Becker et al. 
[22]. Rats were between 32-44 weeks of age at the end of the study. Rats were 
monitored for a minimum of 2 complete cycles (often up to 4 cycles) to obtain sample 
groups at each stage of the estrous cycle. 
 
2.2 Blood and tissue collection and preparation 
Fed blood samples from the tail vein were taken between 13.00 and 15.00, after 
completion of estrous monitoring, the day before the cycle stage to be studied. Some 
animals did not progress as predicted with their estrous cycle, so there is a mismatch 
between the number of animals in the fasted state cycle stages (proestrus n=12; 
estrus n=11; metestrus n=9, diestrus n=11) and the numbers obtained for the fed 
cycle stages the day before (proestrus n=14; estrus n=7; metestrus n=6, diestrus 
n=16). 
 
Rats were fasted from 08.00, before the beginning of the dark period (when 
maximum food consumption occurs), 4 – 8 hours prior to culling. Cage food was 
removed at 08.00 the day after tail vein fed sample collection, and animals were then 
sacrificed between 12.00 and 16.00. Fed blood samples were immediately acidified 
by dilution at 1:10 in buffer (0.1 M ammonium acetate, 0.5 M NaCl, pH 3.6) as 
recommended for optimal peptide preservation and recovery [23]. Rats were 
anaesthetised and decapitated, and a fasted blood sample was obtained from trunk 
blood. All blood was collected into EDTA coated tubes with a protease inhibitor. 
Stomachs were removed and masses were recorded both before and after opening 
along the greater curvature and rinsing in PBS, enabling the mass of remaining 
stomach contents to be calculated. Samples of descending colon were removed and 
immediately frozen for later peptide extraction and assay.  
 
2.3 Radioimmunoassays 
Samples of fed and fasted plasma and fasted colon tissue extract were analysed 
according to the manufacturer’s protocol for total PYY and GLP-1 concentrations 
using radioimmunoassay kits of the same batch number per peptide (Millipore, UK). 
All tissue samples were diluted prior to addition to RIAs using distilled water. Fasted 
plasma samples for GLP-1 measurement were extracted and added to each kit as 
outlined in the assay protocol. Samples were added to assays based on sample 
type, not cycle stage. PYY: intra-assay %CV: 2.97 ± 1.617 (n=3), inter-assay %CV: 
2.85 ± 3.172 (n=3). GLP-1: intra-assay %CV: 3.34 ±1.279 (n=3), inter-assay %CV: 
6.28 ± 1.551 (n=3). 
 
2.4 Statistics 
Values represent mean ± S.E.M. Statistical analysis was carried out using a one-way 
ANOVA with a Tukey post-hoc test on normally distributed data. When data were not 
normally distributed, and could not be transformed (e.g. by log transformation) to 
normality, a Kruskal-Wallis test was used, with follow-up pairwise comparisons 
(Mann-Whitney), with Bonferroni correction. A paired-samples t-test was used to 
compare hormones in the fed and the fasted state. Further statistical testing used a 
univariate general linear model (GLM) with PYY or GLP-1 concentration as the 
primary dependent variable and fed/fasted status and stage in cycle as independent 
variables, with age in weeks as a covariate. To evaluate our secondary aims, 
Pearson correlations were used to determine if either hormone concentrations were 
correlated in fed and fasted states and with age. All statistical tests were performed 
using IBM SPSS Statistics 21. P<0.05 was considered statistically significant.  
 
3. Results 
At culling, the mean age of the rats was 38 ± 0.49 weeks (32 – 44 weeks) and mean 
body mass was 269.2 ± 2.59 g (239.6 – 303.9 g). There were no significant 
differences in age (P=0.180) or body mass (P=0.673) between the different cycle 
stage groups using ANOVA. There was no difference in body mass with age 
(P=0.555). 
 
3.1 Fasted stomach contents indicated least food consumed leading up to estrus 
Stomach contents data were analysed against the cycle stage of the preceding day, 
as the rats were fasted from the beginning of the cull day (from 08.00; before lights 
off at 11.00), therefore analysis of remaining stomach contents provided an 
indication of food consumption during the previous day/cycle stage. When fasted 
from estrus and dissected at metestrus, rats had significantly (F(3, 39)=3.187, 
P=0.034) more stomach contents (0.96 g) than those fasted from proestrus and 
dissected at estrus (0.44 g; P=0.028) [21]. 
 
3.2 GLP-1 
GLP-1 concentrations in fed plasma (101.6 ± 13.15 pg/ml) were significantly 
(t(41)=5.266, P<0.001) higher (approximately three times) than in fasted plasma 
(28.4 ± 15.17 pg/ml) in the whole group. Fed plasma had significantly (Kruskal-
Wallis, χ2=7.871, 3 df, P=0.049) more GLP-1 during proestrus than in diestrus 
(P=0.034; Figure 1 i). Fasted plasma concentrations of GLP-1 were similar at each 
cycle stage (Figure 1 ii). Higher large intestine tissue concentrations were also found 
at proestrus: in descending colon tissue (Figure 1 iii), GLP-1 was significantly more 
concentrated (F(3, 39)=3.921, P=0.015) at proestrus than during estrus (P=0.045) 
and diestrus (P=0.029).  
 
As the experimental design included multiple factors including fed and fasted status 
and stage of ovarian cycle, GLM univariate analysis was used to test for any 
interactions. Although rats used for the study were within a limited age range, 
hormone concentrations may vary with age, so cull age was added into the linear 
model as a covariate. There were significant main (direct) effects of fed/fasted status 
(F(1,76)=36.851, P=0.001), ovarian cycle stage (F(3,76)=3.024, P=0.035) and age 
(F(1,76)=5.729, P=0.019) on total GLP-1 plasma concentrations and a significant 
interaction (joint effect) of fed/fasted status with ovarian cycle stage (F(3,76)=2.766, 
P=0.048) as fixed factors, with age included in the model as a covariate. There was 
no effect of body mass (P=0.531) or empty stomach mass (P=0.124). 
 
Tukey post hoc tests were used to investigate the sources of interaction, with 
significant differences between fed and fasted cycle stage groups shown on Figure 
1(i) and (ii). Fed proestrus rats had the highest GLP-1 plasma concentrations and 
higher amounts than all fasted cycle stages. Fed proestrus GLP-1 concentrations 
were also higher than fed diestrus rats (P<0.001, Fig 1 i). Fed estrus rats also had 
higher GLP-1 than all fasted cycle stages: proestrus, metestrus (P<0.05; with trends 
for estrus P=0.056, ns and diestrus P=0.073, ns). 
 
Figure 1. GLP-1 concentrations during the rat estrous cycle 
Fed plasma (i) and descending colon (iii) GLP-1 were significantly increased at 
proestrus compared to diestrus, and additionally at metestrus in colon tissue. No 
changes were seen in fasted plasma GLP-1 levels (ii) throughout the cycle (* 
P<0.05). General linear modelling univariate analysis differences are shown between 
cycle stages in fed samples (i) and between fed (i) and fasted (ii) figures (a>b, 
P<0.001, c>d, P<0.05. 
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3.3 Plasma, but not colon tissue GLP-1 concentrations were different with age 
General linear modelling (GLM) of GLP-1 data analysis also revealed a significant 
main (direct) effect of age on plasma concentrations of GLP-1, and furthermore, 
scatterplots of the data (Figure 2) show fed and fasted plasma GLP-1 concentrations 
correlated with age: fed negatively (r=-0.534, P<0.001, n=42, Figure 2 i) and fasted 
positively (r=0.445, P=0.003, n=43, Figure 2 ii). Younger rats had higher fed GLP-1 
concentrations, whereas they had lower fasted concentrations, in comparison with 
slightly older animals. GLM also showed that colon tissue levels were not affected by 
age (Figure 2 iii). 
 
Figure 2 Correlation of plasma GLP-1 concentrations and rat age in weeks  
(i) fed GLP-1 (r=-0.534, P<0.001, n=42); (ii) fasted GLP-1 (r=0.445, P=0.003, n=43); 
(iii) descending colon GLP-1 (r=0.221, P=0.154, ns). Note y axes scales and units 
differ (proestrus, ●; estrus, ○; metestrus, ♦; diestrus, ◊). 
 
 
3.4 PYY 
Matched fed and fasted plasma sample analysis for the whole group showed that 
PYY concentrations were significantly (t(41)=13.397, P<0.001) higher (approximately 
twice) in the fed state (453.6 ± 20.05 pg/ml) than the fasted state (177.6 ± 7.18 
pg/ml). The consistent decreases in both PYY and GLP-1 in the circulation from fed 
to fasted states confirmed an adequate fasting time in these animals.  
i) ii) 
iii) 
 There were no significant differences in either fed or fasted plasma concentrations of 
PYY in the different cycle stage groups (Figure 3 i, ii). Concentrations of PYY in the 
descending colon (Figure 3 iii) did not differ significantly between the cycle stages. 
GLM univariate analysis did not reveal any differences in total PYY plasma 
concentrations in fed or fasted states, between ovarian cycle stages or with age in 
the same animals/samples that did have GLP-1 differences. There were no 
significant correlations between fed or fasted PYY concentrations with age. 
 
Figure 3. PYY concentrations during the rat estrous cycle  
Neither fed (i) nor fasted (ii) plasma PYY differed with cycle stage. Descending colon 
PYY (iii) varied with cycle stage, but not significantly. 
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Figure 4 Correlation of plasma PYY concentrations and rat age in weeks  
(i) fed PYY (r=0.143, P=0.368, ns); (ii) fasted PYY (r=0.278, P=0.071, ns); (iii) 
descending colon PYY (r=0.469, P=0.002). Note y axes units differ (proestrus, ●; 
estrus, ○; metestrus, ♦; diestrus, ◊). 
 4. Discussion 
This study has established that circulating and colon tissue concentrations of GLP-1 
were altered at defined stages of the rat estrous cycle. During proestrus, GLP-1 
concentrations were significantly highest in descending colon tissue as well as in fed 
plasma. These increases in the anorexigenic hormone GLP-1 occurred in advance of 
the onset of the estrus phase of the cycle, in agreement with previously reported 
decreased feed intakes [1-3]. Increased expression of Glp-1r has previously been 
demonstrated in the hypothalamus and ovaries at proestrus in Sprague-Dawley rats 
[24], suggesting increased responsiveness to GLP-1 at this time, when circulating 
levels are high. Despite being secreted from the same cell type as GLP-1, neither 
fed nor fasted PYY plasma or tissue concentrations differed at defined stages of the 
cycle, although descending colon PYY individual concentrations varied considerably 
within each group. Approximately 70% of colonic L cells co-secrete PYY [reviewed 
i) ii) 
iii) 
by 15], so it is likely that differential secretion of GLP-1 and PYY takes place 
throughout the rat ovarian cycle. We measured total concentrations, so the 
possibility remains that the proportions of the different forms of PYY [14] could be 
altered at different stages, despite the absence of any increases in total levels, as 
were found for GLP-1; and requires further study to determine. 
 
GLP-1 acts as an incretin, signalling between the gut and pancreatic beta cells to 
increase glucose-dependent insulin secretion [14], but as GLP-1 secretion starts to 
occur before glucose reaches the distal gut in rats, the initial release is thought to be 
vagally stimulated [25]. This initial increase is followed later by the direct GLP-1 
stimulatory effect of nutrients arriving at the distal L cells. Diurnal variations of GLP-1 
secretion in male rats in response to oral glucose administration have been 
demonstrated [25], and were limited to the first phase response. Therefore, if this 
also occurs in female rats, this earlier ‘non nutrient’ mechanism may be involved in 
the increased GLP-1 secretion observed prior to the estrus phase. However, it 
likewise remains possible that differences in other hormones, neuropeptides, or 
nutrients that stimulate second phase GLP-1 secretion such as insulin, gastric 
inhibitory polypeptide (GIP) or leptin, which activate Erk1/2 or AKT; cAMP and 
STAT3 signalling mechanisms in L cells, respectively, could also be involved in the 
differences observed in this study.  Further research is needed in females to explore 
the secretory patterns of cells in different areas of the gastrointestinal tract (similar to 
work done by Svendsen et al., [16] on male rat perfused small intestine) and confirm 
the possibility of differential release of PYY and GLP-1 throughout the oestrous 
cycle.  
 
Studies have demonstrated a link between high exogenously administered GLP-1 
levels and a reduction in food intake in rats [26] and humans [27], and also a 
reduction in the intake of high-fat food in mice when injected centrally [28]. As the 
animals used in the present study were group housed, daily food intake with cycle 
stage could not be monitored closely, but weighing stomach contents at dissection 
provided an indication of food and water consumption based on what remained after 
the fasting period. The mass of remaining stomach contents indicated that the rats 
either consumed the least between proestrus and estrus and the most shortly after, 
or that stomach emptying may have been inhibited by higher GLP-1 concentrations 
during proestrus. Increased levels of both GLP-1 and PYY have been linked with a 
reduced gut transit time in rodents [29, 30] and humans [31, 32]. Although gastric 
motility has not been studied during the ovarian cycle, it has been reported that there 
is reduced food intake during the stage of proestrus [1-3, 33, 34]. These combined 
observations suggest that satiety was likely increased leading into estrus, further 
supported by the increased endogenous GLP-1 findings from this study.  
 
Due to the important timing, close to potential conception, it is possible that an 
increase in GLP-1 at proestrus may also be involved in setting appropriate 
metabolic/nutritional conditions for vital reproductive events taking place at this 
critical stage of the ovarian cycle. Recent studies of the orexigenic gut hormone 
ghrelin found that both hyper- and hypoghrelinemia had negative effects throughout 
fertilisation, implantation, and both embryo and fetal developmental stages in mice 
[35]. That study demonstrated the importance of optimal ghrelin levels from the 
fertilisation period and during the very early stages of pregnancy. Likewise in this 
study, from proestrus to estrus when the rats were sexually receptive, higher fed and 
tissue GLP-1 levels may have provided a permissive signal of adequate nutritional 
reserves to support pregnancy, enhanced insulin sensitivity and acted to delay or 
prolong nutrient absorption by slowing gastric emptying and intestinal transit [15]. 
This hypothesis is consistent with the finding that descending colon GLP-1 levels 
were increased despite the period of fasting, which would be expected to decrease 
GLP-1 production to increase appetite; also that the fed plasma samples from 
proestrus rats taken the day before had the highest concentrations. In support of this 
possibility, another recent study has demonstrated regulatory links between GLP-1 
and the hypothalamic-gonadal-pituitary axis and increased litter size in female rats 
[24]. 
 
The increasing incidence of obesity in females of reproductive age (with suppressed 
GLP-1, PYY and ghrelin concentrations) across the globe [36] is of concern for the 
health of these women and their offspring. The evidence for an effect of parental diet 
and body composition on metabolic programming and epigenetic changes of 
offspring before [37, 38], during and after conception and implantation [39, 40] is 
growing. Mice with diet-induced obesity have been shown to have poor oocyte 
quality leading to poor blastocyst survival rates and embryos that survived showed 
multiple abnormalities such as aneuploidy [41]. Human fetuses are also at risk, 
presenting with growth retardation and brain development abnormalities [42]. Obese 
women are known to have impaired reproductive function and can suffer infertility, 
miscarriage and further, obstetric complications [43], so it is essential that more is 
understood about the role of gut hormones in normal eating behaviour and 
fundamental reproductive functions, particularly at the time of conception.   
 
This study has also revealed interactions between fed/fasted status and cycle stage 
on GLP-1 plasma concentrations with increasing age in reproductively competent 
rats (between 32 and 44 weeks of age), but not on co-secreted PYY. Both fed and 
fasted total ghrelin (appetite-enhancing) concentrations from these plasma samples 
[21] were likewise significantly reduced in the slightly older animals. GLP-1 and 
ghrelin are both involved, in opposing roles, in glucose homeostasis [39]. This 
current work provides further evidence that total GLP-1 concentrations are an 
important component of the complex dynamic physiological changes taking place in 
the ovarian cycle of female rats. Furthermore, if the regulatory control of appetite-
influencing hormones such as GLP-1 and ghrelin are attenuated between fed and 
fasted states with increasing age in reproductively competent females, such changes 
could impact on dam body composition, reproductive success and offspring 
metabolic programming.  
 
5. Conclusion 
These new findings that GLP-1 concentrations are increased in fed plasma and 
descending colon tissue at proestrus, whilst PYY are not, and that there are 
interactions between fed/fasted status, ovarian cycle and age (whilst still 
reproductively competent), add to the existing knowledge about natural food intake 
reductions during the ovarian cycle in rats. Alterations in anorexigenic gut hormone 
concentrations and fasted stomach contents at proestrus could contribute to the 
reported reduction in food intake during estrus in rats, in addition to the known 
effects of estradiol. There is growing evidence that so-called appetite hormones act 
as signals to the reproductive tract of an optimal nutritional environment to support 
pregnancy. As GLP-1 concentrations are also implicated in glucose regulation, 
studying this gut hormone throughout reproductive life stages is important for 
examining the links between maternal appetite and glucose regulation and how this 
may be implicated in the metabolic programming of offspring. 
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